Stock SUNLOC6 SUNIL HEALTHCARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sunil Healthcare Limited

Equities

SUNLOC6

INE671C01016

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 11:00:53 13/05/2024 BST 		5-day change 1st Jan Change
81.4 INR -4.20% Intraday chart for Sunil Healthcare Limited -13.51% +48.51%
02-14 Sunil Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
2023 Sunil Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 698.3 351.2 152.3 234.3 730.1 584.8
Enterprise Value (EV) 1 1,296 890.9 613.3 727 1,074 926.1
P/E ratio 15.5 x -50.8 x -3.07 x -36.7 x 11.4 x 8.75 x
Yield - - - - - -
Capitalization / Revenue 0.76 x 0.43 x 0.22 x 0.26 x 0.61 x 0.53 x
EV / Revenue 1.42 x 1.1 x 0.88 x 0.81 x 0.9 x 0.84 x
EV / EBITDA 9.36 x 8.22 x -14.4 x 8.62 x 6.13 x 5.97 x
EV / FCF -6.68 x 14 x 16 x -19.7 x 9.7 x -43.9 x
FCF Yield -15% 7.12% 6.23% -5.07% 10.3% -2.28%
Price to Book 1.47 x 0.75 x 0.34 x 0.54 x 1.46 x 1.04 x
Nbr of stocks (in thousands) 10,255 10,255 10,255 10,255 10,255 10,255
Reference price 2 68.10 34.25 14.85 22.85 71.20 57.03
Announcement Date 03/09/18 03/09/19 05/09/20 06/09/21 30/08/22 02/09/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net sales 1 916.2 812 700.2 902.9 1,192 1,105
EBITDA 1 138.6 108.4 -42.74 84.36 175.4 155.1
EBIT 1 91.2 51.45 -102 25.18 115 91.74
Operating Margin 9.95% 6.34% -14.56% 2.79% 9.65% 8.3%
Earnings before Tax (EBT) 1 63.11 -8.764 -30 -5.532 92.65 94.83
Net income 1 44.94 -6.916 -49.64 -6.379 64.21 66.82
Net margin 4.9% -0.85% -7.09% -0.71% 5.39% 6.05%
EPS 2 4.380 -0.6744 -4.840 -0.6221 6.261 6.516
Free Cash Flow 1 -194.2 63.46 38.24 -36.87 110.8 -21.11
FCF margin -21.19% 7.82% 5.46% -4.08% 9.29% -1.91%
FCF Conversion (EBITDA) - 58.57% - - 63.16% -
FCF Conversion (Net income) - - - - 172.51% -
Dividend per Share - - - - - -
Announcement Date 03/09/18 03/09/19 05/09/20 06/09/21 30/08/22 02/09/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 598 540 461 493 344 341
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 4.317 x 4.981 x -10.79 x 5.84 x 1.962 x 2.2 x
Free Cash Flow 1 -194 63.5 38.2 -36.9 111 -21.1
ROE (net income / shareholders' equity) 9.95% -1.47% -5.18% -1.44% 13.7% 12.6%
ROA (Net income/ Total Assets) 4.37% 2.3% -4.76% 1.25% 6.24% 4.98%
Assets 1 1,029 -301.1 1,043 -508.3 1,029 1,343
Book Value Per Share 2 46.30 45.60 43.50 42.60 48.70 54.60
Cash Flow per Share 2 0.7900 1.080 1.310 0.5400 0.2600 0.5700
Capex 1 156 55.9 8.15 68.4 90.4 42
Capex / Sales 17.04% 6.88% 1.16% 7.58% 7.59% 3.8%
Announcement Date 03/09/18 03/09/19 05/09/20 06/09/21 30/08/22 02/09/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
SUNIL HEALTHCARE LIMITED Stock Sunil Healthcare Limited
+48.51% 10.43M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+21.09% 43.27B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+25.28% 22.92B
SANDOZ GROUP AG Stock Sandoz Group AG
+19.22% 15.43B
CIPLA LIMITED Stock Cipla Limited
+13.51% 12.95B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+44.01% 11.83B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-7.79% 6.91B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+13.02% 5.55B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SUNLOC6 Stock
  4. Financials Sunil Healthcare Limited